Bill
Bill > SB1032
summary
Introduced
02/17/2026
02/17/2026
In Committee
02/17/2026
02/17/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
This bill creates a sales and use tax exemption for the sale of over-the-counter drugs. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. For further information see the state fiscal estimate, which will be printed as an appendix to this bill.
AI Summary
This bill creates a new exemption from sales and use taxes for the sale of over-the-counter drugs, which are defined as medications that have a label identifying them as drugs and include a "drug facts panel" or a statement of active ingredients as required by federal regulations (21 CFR 201.66). This means that when this bill becomes law, consumers will no longer have to pay sales tax on these types of medications, making them more affordable. The bill also specifies that this exemption will take effect on the first day of the third month after its publication.
Committee Categories
Budget and Finance
Sponsors (17)
Tim Carpenter (D)*,
Dianne Hesselbein (D)*,
Melissa Ratcliff (D)*,
Jeff Smith (D)*,
Mark Spreitzer (D)*,
Bob Wirch (D)*,
Andrew Hysell (D),
Alex Joers (D),
Tara Johnson (D),
Vincent Miresse (D),
Greta Neubauer (D),
Lori Palmeri (D),
Ann Roe (D),
Joe Sheehan (D),
Christine Sinicki (D),
Lee Snodgrass (D),
Shelia Stubbs (D),
Last Action
Read first time and referred to Committee on Agriculture and Revenue (on 02/17/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://docs.legis.wisconsin.gov/2025/proposals/reg/sen/bill/sb1032 |
| BillText | https://docs.legis.wisconsin.gov/document/proposaltext/2025/REG/SB1032.pdf |
Loading...